EOM Pharmaceuticals Holdings, Inc. (IMUC)

IMUC Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Sep 10, 2026	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24	21	-
Market Cap Growth	113.85%	-	-
Last Close Price	0.19	0.42	-

Price Ratios

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Sep 10, 2026	Dec 31, 2021	Dec 31, 2020
PB Ratio	-6.44	-12.81	-

Financial Efficiency

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Sep 10, 2026	Dec 31, 2021	Dec 31, 2020
Debt / Equity Ratio	-0.82	-1.74	-
Net Debt / Equity Ratio	-0.67	-0.82	-2.03
Quick Ratio	0.75	3.20	1.92
Current Ratio	0.97	3.58	1.92
Return on Assets (ROA)	-440.45%	-169.00%	-
Return on Capital Employed (ROCE)	12683.60%	-217.60%	-1495.10%

Yields

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Sep 10, 2026	Dec 31, 2021	Dec 31, 2020
Earnings Yield	-21.34%	-24.88%	-
Buyback Yield / Dilution	-118.93%	-5.46%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 20, 2022

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error